About
Team
Blog
Approach
Gene Circuit Technology Platform
Off-the-Shelf NK Cells
Scientific Presentations & Publications
Pipeline
Partnering
Investors
Overview
Press Releases
Events & Presentations
Financials & Filings
Corporate Governance
Documents & Charters
Leadership Team
Board of Directors
Committee Composition
Stock Information
Investor Resources
FAQ
Email Alerts
Contact Us
Careers
News
Press Releases
All
2022
2021
2020
2019
2018
Senti Bio Names Dr. Kanya Rajangam to Newly Created Position of Chief Medical and Development Officer
05/25/2022
Senti Bio Secures Additional Financing from Leaps by Bayer and Provides Update on Proposed Business Combination with Dynamics Special Purpose Corp. (DYNS)
05/24/2022
Senti Bio Highlights Preclinical Data on Cancer-Killing Allogeneic CAR-NK Cells in Three Presentations at ASGCT Annual Meeting
05/18/2022
Senti Bio to Present Data from Gene Circuit-Engineered Allogeneic CAR-NK Cell Therapy Pipeline at Upcoming Scientific Conferences
05/02/2022
Senti Bio to Present at Chardan’s 6th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
Listen to the Chardan Webcast
04/18/2022
Senti Bio Presents New Preclinical Data on Cancer-Killing Allogeneic CAR-NK Cells at AACR Annual Meeting
04/08/2022
Senti Bio to Present Preclinical Data on Cancer-Killing Allogeneic CAR-NK Cells at AACR Annual Meeting
03/08/2022
Senti Bio to Present at the 40th Annual J.P. Morgan Virtual Healthcare Conference
Download the JPM Presentation
01/06/2022
1
(current)
